思略特：2025医疗健康的未来：新兴LIFEcare生态体系中生物制药企业商业模式的重塑报告（英文版）（32页）.pdf

1、Future of HealthHow BioPharma must reinvent their business models to succeed in the emerging LIFEcare ecosystem#FutureOfHealthContactsGlobalAnthony BruceGlobal Health Industries LeaderPartner,PwC UK+44-7801-916-EuropeDr.Thomas Solbach Pharma and Life Sciences Leader EuropePartner,PwC Strategy&German

2、y+49-170-2238-Fritz HeesePartner,PwC Strategy&Germany+49-170-858- Roland WernerHealth Industries Leader GermanyPartner,PwC Germany+49-170-7628-United StatesGreg RotzPartner,PwC Strategy&US+1-703-682- JapanShunsuke HoriiPartner,PwC Strategy&Japan+81-80-3317-United KingdomThalita MarinhoPartner,PwC St

3、rategy&UK+44-0790-016-IndiaSujay ShettyPartner,PwC India+91-98677-00030 AustraliaNick MeadowsDirector,PwC Strategy&Australia+61-499-426-899nicholas.a.meadows ChinaJia Xu Partner,PwC Strategy&China+86-10-6533-7734 jia.x.xu Strategy&|Future of Health3Dr.Thomas Solbach advises clients in the healthcare

4、 and life sciences industry globally.He specializes in helping biopharma,diagnostics,and digital health solution providers to develop differentiated strategies,capabilities,innovations and resilient operating models with a particular focus on precision medicine.He leads Strategy&s Europe pharma and

5、life sciences practice.Based in Frankfurt,he is a Partner with PwC Strategy&Germany.Fritz Heese advises pharmaceutical and life sciences companies across Europe and the US.He specializes in achieving significant results in commercial transformation,business model reinvention,and organizational&finan

6、cial performance.Based in Hamburg,he is a Partner at PwC Strategy&Germany.Anthony Bruce advises clients in the healthcare,pharmaceuticals,and life sciences industry globally.He specializes in helping healthcare,pharmaceuticals,and life sciences providers to develop robust operating models,drive inno